Ordering Recommendation

  • Determine quantity of tissue plasminogen ( tPA) in plasma.
  • May be helpful in detecting disorders of the fibrinolytic system.
  • Not a first-line test for diagnosing inherited thrombotic or bleeding disorders.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Lt. blue (sodium citrate). Refer to Specimen Handling at aruplab.com for hemostasis/thrombosis specimen handling guidelines.

Specimen Preparation

Separate plasma from cells and freeze ASAP. Transfer 1 mL platelet-poor plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)

Storage/Transport Temperature

CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered.

Unacceptable Conditions

Serum, EDTA plasma, clotted or hemolyzed specimens.

Remarks
Stability

Ambient: 4 hours; Refrigerated: Unacceptable; Frozen: 2 months

Methodology

Enzyme-Linked Immunosorbent Assay

Performed

Tue

Reported

1-8 days

Reference Interval

Effective October 6, 2014
≤12.4 ng/mL

Interpretive Data



Compliance Category

FDA

Note

Hotline History

N/A

CPT Codes

85415

Components

Component Test Code* Component Chart Name LOINC
0099187 Tissue Plasminogen Activator Antigen 5971-7
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • TPA Antigen
Tissue Plasminogen Activator, Antigen